The Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Author(s) -
Pamela Kushner,
Davida F. Kruger
Publication year - 2020
Publication title -
clinical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.931
H-Index - 37
eISSN - 1945-4953
pISSN - 0891-8929
DOI - 10.2337/cd19-0093
Subject(s) - glycemic , medicine , continuous glucose monitoring , target range , diabetes mellitus , blood glucose self monitoring , focus (optics) , metric (unit) , intensive care medicine , blood glucose monitoring , endocrinology , operations management , computer science , artificial intelligence , physics , optics , economics
Continuous glucose monitoring (CGM) provides comprehensive assessment of daily glucose measurements for patients with diabetes and can reveal high and low blood glucose values that may occur even when a patient's A1C is adequately controlled. Among the measures captured by CGM, the percentage of time in the target glycemic range, or "time in range" (typically 70-180 mg/dL), has emerged as one of the strongest indicators of good glycemic control. This review examines the shift to using CGM to assess glycemic control and guide diabetes treatment decisions, with a focus on time in range as the key metric of glycemic control.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom